|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Assets | |||||||||
| Fixed maturity securities, available-for-sale at fair value (amortized cost $1,651,797 in 2021 and $2,159,743 in 2020, allowance for credit losses $(1,011) in 2021 and $(1,457) in 2020) | |||||||||
| Commercial levered loans at amortized cost (fair value $5,269 in 2021 and $12,180 in 2020) | |||||||||
| Non-redeemable preferred stock securities at fair value (amortized cost $11,670 in 2020 and $0 in 2019) | |||||||||
| Non-redeemable preferred stock securities at fair value (cost $1,400 in 2021 and $6,541 in 2020) | |||||||||
| Bond exchange-traded funds at fair value (cost $0 in 2021 and $44,679 in 2020) | |||||||||
| Limited partnerships and limited liability companies at fair value (cost $72,814 in 2021 and $74,268 in 2020) | |||||||||
| Short-term investments | |||||||||
| Total investments | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Accrued investment income | |||||||||
| Premiums and other receivables, net | |||||||||
| Receivable from reinsurers on paid losses, net | |||||||||
| Reinsurance receivables on unpaid losses, net | |||||||||
| Deferred policy acquisition costs | |||||||||
| Prepaid reinsurance premiums | |||||||||
| Net deferred income taxes | |||||||||
| Goodwill and net intangible assets | |||||||||
| Fixed assets and capitalized software, net | |||||||||
| Funds withheld related to sale of affiliate | |||||||||
| Other assets | |||||||||
| Assets of discontinued operations | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Reserve for unpaid losses and loss adjustment expenses | |||||||||
| Reserve for unearned premiums | |||||||||
| Ceded reinsurance payable | |||||||||
| Notes payable, net of debt issuance costs | |||||||||
| Secured notes payable, net of issuance costs | |||||||||
| Funds held under reinsurance agreements | |||||||||
| Net deferred income taxes | |||||||||
| Other liabilities | |||||||||
| Liabilities of discontinued operations | |||||||||
| Total liabilities | |||||||||
| Stockholders' equity | |||||||||
| Common stock, $0.01 par value; 200,000,000 shares authorized; 43,632,764 and 43,449,087 shares issued, 43,619,844 and 43,436,167 shares outstanding in 2021 and 2020, respectively | |||||||||
| Paid-in capital | |||||||||
| Accumulated other comprehensive income | |||||||||
| Retained deficit | |||||||||
| Treasury shares - at cost (12,920 shares) | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
